RU2011152105A - Составы таблеток 3-цианохинолина и их применение - Google Patents

Составы таблеток 3-цианохинолина и их применение Download PDF

Info

Publication number
RU2011152105A
RU2011152105A RU2011152105/15A RU2011152105A RU2011152105A RU 2011152105 A RU2011152105 A RU 2011152105A RU 2011152105/15 A RU2011152105/15 A RU 2011152105/15A RU 2011152105 A RU2011152105 A RU 2011152105A RU 2011152105 A RU2011152105 A RU 2011152105A
Authority
RU
Russia
Prior art keywords
composition
weight
amount
approximately
microcrystalline cellulose
Prior art date
Application number
RU2011152105/15A
Other languages
English (en)
Russian (ru)
Inventor
Голди КАУЛ
Рамарао ЧАТЛАПАЛЛИ
Арвиндер НЭЙДЖИ
Кришненду ГХОШ
Original Assignee
УАЙТ ЭлЭлСи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by УАЙТ ЭлЭлСи filed Critical УАЙТ ЭлЭлСи
Publication of RU2011152105A publication Critical patent/RU2011152105A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
RU2011152105/15A 2009-07-02 2010-06-30 Составы таблеток 3-цианохинолина и их применение RU2011152105A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22253709P 2009-07-02 2009-07-02
US61/222,537 2009-07-02
PCT/US2010/040555 WO2011002857A2 (fr) 2009-07-02 2010-06-30 Formulations de comprimé de 3- cyanoquinoline et leurs utilisations

Publications (1)

Publication Number Publication Date
RU2011152105A true RU2011152105A (ru) 2013-08-10

Family

ID=42732381

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2011152105/15A RU2011152105A (ru) 2009-07-02 2010-06-30 Составы таблеток 3-цианохинолина и их применение

Country Status (15)

Country Link
EP (1) EP2448563A2 (fr)
JP (1) JP2011012063A (fr)
KR (1) KR20120046216A (fr)
CN (1) CN102470109A (fr)
AR (1) AR077546A1 (fr)
AU (1) AU2010266342A1 (fr)
BR (1) BRPI1015941A2 (fr)
CA (1) CA2766067A1 (fr)
IL (1) IL217298A0 (fr)
MX (1) MX2012000048A (fr)
RU (1) RU2011152105A (fr)
SG (1) SG177309A1 (fr)
TW (1) TW201113050A (fr)
WO (1) WO2011002857A2 (fr)
ZA (1) ZA201200366B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102886045A (zh) 2005-02-03 2013-01-23 综合医院公司 治疗吉非替尼耐药性癌症的方法
KR101354828B1 (ko) 2005-11-04 2014-02-18 와이어쓰 엘엘씨 ｍＴＯＲ 저해자, 헤르셉틴, 및/또는 ＨＫＩ-272의항신생물성 조합
US8022216B2 (en) 2007-10-17 2011-09-20 Wyeth Llc Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
EP3135285B1 (fr) 2008-06-17 2018-08-15 Wyeth LLC Combinaisons antinéoplasiques contenant du hki-272 et de la vinorelbine
EP2326329B1 (fr) 2008-08-04 2017-01-11 Wyeth LLC Combinaisons antinéoplasiques de 4-anilino-3-cyanoquinoléines et de capécitabine
DK3000467T3 (da) 2009-04-06 2023-03-27 Wyeth Llc Behandling med neratinib mod brystkræft
FI2498756T4 (fi) * 2009-11-09 2023-03-22 Neratinibimaleaatin tablettiformulaatiot
ES2729677T3 (es) 2009-11-09 2019-11-05 Wyeth Llc Esferoides de fármacos recubiertos y sus usos para eliminar o reducir condiciones, como la emesis y la diarrea
CN104447541A (zh) * 2013-09-16 2015-03-25 天津市汉康医药生物技术有限公司 博舒替尼化合物
CN105384686B (zh) * 2014-09-04 2019-07-26 连云港润众制药有限公司 一种博舒替尼结晶方法
WO2017175855A1 (fr) * 2016-04-08 2017-10-12 Shionogi & Co., Ltd. Forme posologique solide stabilisée
WO2018181574A1 (fr) 2017-03-31 2018-10-04 日精エー・エス・ビー機械株式会社 Contenant en résine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6297258B1 (en) 1998-09-29 2001-10-02 American Cyanamid Company Substituted 3-cyanoquinolines
MY135609A (en) * 2002-02-26 2008-05-30 Astrazeneca Ab Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
MXPA06001590A (es) 2003-08-19 2006-05-19 Wyeth Corp Proceso para la preparacion de 4-amino-3-quinolincarbonitrilos.
EP1797881B1 (fr) * 2004-09-17 2009-04-15 Eisai R&D Management Co., Ltd. Composition medicamenteuse avec une stabilite amelioree et une tendence de gelification reduite
PL1902029T5 (pl) * 2005-07-01 2022-08-29 Wyeth Llc Krystaliczne postacie 4-[(2,4-dichloro-5-metoksyfenylo)amino]-6-metoksy-7-[3(-4-metylo-1-piperazynylo)propoksy]-3-chinolino-karbonitrylu i sposoby ich wytwarzania
WO2008053295A2 (fr) * 2006-10-30 2008-05-08 Wockhardt Research Centre Compositions pharmaceutiques d'acide benzoquinolizine-2-carboxylique
CN101224185A (zh) * 2007-12-11 2008-07-23 山东蓝金生物工程有限公司 一种治疗实体肿瘤的伯舒替尼缓释植入剂

Also Published As

Publication number Publication date
KR20120046216A (ko) 2012-05-09
IL217298A0 (en) 2012-02-29
ZA201200366B (en) 2012-10-31
CN102470109A (zh) 2012-05-23
WO2011002857A2 (fr) 2011-01-06
WO2011002857A3 (fr) 2011-03-10
TW201113050A (en) 2011-04-16
AU2010266342A1 (en) 2012-01-19
SG177309A1 (en) 2012-02-28
MX2012000048A (es) 2012-01-27
CA2766067A1 (fr) 2011-01-06
EP2448563A2 (fr) 2012-05-09
BRPI1015941A2 (pt) 2016-04-19
JP2011012063A (ja) 2011-01-20
AR077546A1 (es) 2011-09-07

Similar Documents

Publication Publication Date Title
RU2011152105A (ru) Составы таблеток 3-цианохинолина и их применение
HRP20192026T4 (hr) Formulacija tableta od neratinib maleata
HRP20190660T1 (hr) FORMULACIJA N-[2,4-bis(1,1-DIMETILETIL)-5-HIDROKSIFENIL]-1,4-DIHIDRO-4-OKSOHINOLIN-3-KARBOKSAMIDA U OBLIKU TABLETE ZA UPOTREBU U TRETMANU CISTIČNE FIBROZE
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
NZ729172A (en) Combination formulation of two antiviral compounds
WO2013016697A3 (fr) Compositions orales contenant un ester de 17-hydroxyprogestérone et procédés s'y rapportant
NZ753904A (en) Compositions and methods for treating anemia
BRPI0403935B8 (pt) formas de dosagem de azitromicina com efeitos colaterais reduzidos
NZ592673A (en) Antisense compositions with enteric coating for treating crohn's disease, colitis and bowel disease
HRP20220902T3 (hr) Pripravci i njihova upotreba u liječenju multiple skleroze
WO2012079092A3 (fr) Compositions d'undécanoate de testostérone
RS54329B1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING RIFAXIMINE, PROCEDURES FOR THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF VAGINAL INFECTIONS
NZ620879A (en) A novel formulation of indomethacin
JP2013531041A5 (fr)
MX2017016823A (es) Composiciones orales que contienen éster de 17- hydroxiprogesterona y métodos relacionados.
RU2011137131A (ru) Производные 1-аминоалкилциклогексана для лечения тиннитуса, связанного с потерей слуха или незначительной потерей слуха
NZ587202A (en) Methods for measuring a patient response upon administration of a drug and compositions thereof
JP2013508289A5 (fr)
BR112012009857A2 (pt) composições farmacêuticas sólidas contendo um inibidor de integrase
RU2010107843A (ru) Бупропиона гидробромид и его терапевтические применения
RU2012142811A (ru) Фармацевтические композиции и пероральные дозированные формы пролекарства леводопы и способы применения
JP2018527305A5 (fr)
RU2013154355A (ru) Способ лечения мезотелиомы ингибитором рi3к
RU2016117186A (ru) Комбинированная композиция, содержащая тадалафил и амлодипин
HRP20180315T1 (hr) Čvrsti oblici soli alfa-6-mpeg6-o-hidroksikodona kao opioidni agonisti i njihove upotrebe